Arimistane Review: OTC Aromatase Inhibitor vs Real AIs

Arimistane is the trade name for androsta-3,5-diene-7,17-dione, a synthetic derivative of a DHEA metabolite. It was sold for years as an over-the-counter "aromatase inhibitor" in PCT stacks and estrogen-control supplements, which is the whole reason it has its own niche: it was the one compound a man could buy without a prescription that inhibited aromatase at all.

Two facts frame everything else in this review. First, the compound is a steroidal aromatase inhibitor in the same broad class as exemestane, and it does suppress estrogen to a measurable degree. Second, the FDA has stated in multiple warning letters that it does not meet the definition of a dietary ingredient and cannot legally be sold in supplements in the US, and WADA bans it at all times as a hormone and metabolic modulator. So the product still turns up on shelves and in "PCT" blends, usually under a rebrand, but its legal footing is gone and its quality control was never there.

This review covers what the compound does, what dose the market uses, what it costs a man in side effects, how it compares with Aromasin, and which men it was ever the right choice for.

The compound binds the aromatase enzyme through a steroidal mechanism, sitting in the active site where androstenedione would go and blocking the conversion of androgens to estrogens. Some sources describe the binding as irreversible, like exemestane's, but the human pharmacokinetic data that would confirm binding characteristics, suppression duration and enzyme recovery do not exist for this compound the way they do for the prescription AIs. The Aromasin half-life guide shows what that data looks like for a drug that has been through clinical development.

What the preclinical work and community logs agree on is that estrogen falls, modestly, at OTC doses. What nobody has is a controlled human dose-response curve. Bodybuilding use of the compound rests on mechanistic plausibility, in-vitro inhibition data, and forum logs, not on trials.

The market sat at the junction of three use cases.

Natural estrogen support: in men with estradiol slightly high relative to testosterone, older men, men carrying body fat, or genetically heavy aromatisers, a weak OTC inhibitor could nudge the ratio without the potency of a prescription AI. This was the one context where the compound's gentleness was a feature.

OTC PCT after prohormones: after the prohormone era, arimistane became the standard "AI" in over-the-counter PCT stacks. The logic was sound as far as it went: some aromatase inhibition during recovery stops estrogen dominating the picture. The flaw is that an AI is not a PCT. Recovery of LH and FSH needs a SERM, and no OTC blend supplies one.

Bridging between cycles: some men ran it off-cycle to hold a favourable ratio at natural testosterone levels, which suits the potency.

None of these is estrogen control on a testosterone cycle, and the aromatase inhibitors for men guide sets out why that job needs a drug.

There is no clinical dosing protocol because there were never clinical trials. Products contained 25–75 mg per serving, with labels suggesting one to three servings a day, for a daily total between 25 and 150 mg.

Because the compound was never assayed under pharmaceutical rules, stated content and actual content diverged between brands, and the only way to know what a given dose did was a sensitive estradiol test before and four weeks into use. Most men never drew one, which is why the forum consensus on its strength is so wide.

The side effect profile mirrors pharmaceutical AIs in kind, because the mechanism is the same; the threshold is higher because the potency is lower.

The how to lower estrogen in men guide covers the blood work that separates a crash from high estrogen, which applies to an OTC inhibitor exactly as it does to a prescription one.

The arimistane vs aromasin comparison resolves to one principle: a man managing estrogen on an anabolic steroid cycle cannot get reliable suppression from the OTC compound. At 500 mg of testosterone a week he runs with high estradiol on any OTC dose. The Aromasin vs Arimidex comparison is the relevant decision for that man, and the Aromasin for sale guide shows that a pharmacy prescription with a discount card now costs less per month than the supplement did.

For a natural man wanting mild support, the comparison is less about potency than about access and legality: exemestane needs a prescription, and the OTC option, in principle, cannot be sold.

As FDA pressure pushed the ingredient off major retailers, the "estrogen blocker for men" shelf refilled with products that contain no aromatase inhibitor at all. EstroControl from Beyond Alpha, Happy Mammoth's Estro Control for men and Estro Guard are DIM-based formulas with NAC, choline, artichoke, vitamin B6 and selenium: liver and estrogen-metabolism support, not enzyme inhibition. They are legal, they are gentler, and they do less. The best estrogen blocker for men guide ranks them alongside the prescription options.

Products that still list arimistane, or its chemical name androsta-3,5-diene-7,17-dione, are worth three checks before buying.

It made sense for a narrow group: natural lifters wanting mild estrogen support without a prescription, men finishing a prohormone run who used it alongside a real SERM, and men bridging between cycles at natural testosterone. Even for them, a sensitive estradiol test was the only way to know whether the dose was doing anything.

It never made sense for estrogen management on a testosterone or other aromatising cycle, for PCT after a steroid cycle, where a SERM plus a short exemestane bridge is the protocol, or for any man with confirmed high estradiol who needed the number moved. With the ingredient's legal status gone and pharmacy exemestane cheaper than the supplement, the case for it has narrowed to almost nothing. The Aromasin dosage guide covers what to run instead at every testosterone level.

Aromasin.org is an independent educational resource. We are not affiliated with Pfizer, any pharmaceutical manufacturer, or healthcare provider. This content is for informational purposes only and does not constitute medical advice.